personal slant to the relevance of the approach and results from chosen areas of research'. The editors have arranged the papers in logical sequence: immunogenetics, lymphocyte function, rheumatoid factors, autoantibodies, immune complexes, complement, macrophages, and the pathogenesis of joint destruction.
I found almost all parts of this volume of intense interest. Rapid advances in understanding of the role of the HLA DR loci in rheumatoid arthritis provide the background for expert discussions on the part played by T lymphocytes in synovial disease and the role of lymphokines. The possibility of rheumatoid factor as a product of a response against antigen cross-reacting with IgG, the biological and chemical properties of anti-IgG antibodies and the immune response to the collagens are among topics criticised and appraised. Although the formation, deposition, and behaviour of immune complexes also provoke fascinating discussion, as do the role of complement and macrophages. I was particularly attracted to the accounts of the part that may be played in protease activation and inhibition by lymphocytes and by the concept that collagenase inhibitors may come to have an increasingly important therapeutic significance.
No one concerned with the rapid advances that are taking place in studies of rheumatoid arthritis should neglect Panayi and Johnson's book. The practising rheumatologist will find it stimulating and thoughtprovoking; the laboratory worker will turn to it for recent information. (4) A synovial membrane of thickness 3 mm is not the usual thickness that one would expect in a hypertrophied rheumatoid synovial membrane removed at synovectomy. Was there evidence of chronic inflammatory synovitis on the histological examination of these synovial membranes and, in particular, of the foreign body reactions associated with the use of silicate as noted by G. Loewi (unpublished observations).
(5) Presumably the surgical synovectomies were of the anterior and accessible part of the synovium only. Bonneton2 noted that much of the injected yttrium radiocolloids collected in the posterior part of the knee in experimental animals. Without information on how much radioactivity would have been in those parts of the synovium that were not removed the figures on retention are relatively meaningless.
(6) Have the authors any evidence for suggesting that further leakage should not occur after the 6th day? Leakage is not normally measured after 6 days because the amount of radioactivity remaining is negligible compared with the first 3 days. Extrapolating in their second patient from a loss of 14% at 6 days, it is not unreasonable that only 10% was found in the anterior synovial membrane 6 weeks later. If the loss continued as an exponential decay, the expected retention in the entire knee would have been 34 %. What happened to the yttrium-90 in their first patient is debateable, but I would expect that a fair amount of it was on fibrin bodies within the cavity of the knee and on the synovium over the femur, tibia, and ligaments and in the posterior cavity of the knee.
J (5) We did not suggest that further leakage does not occur after the sixth day, and our findings indicate that it may indeed occur. However, we have found from measurements on several patients that the knee activity tends to approach a stable value by about the sixth day and that the escape is not exponential after about the fourth day.
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